Review Article
The Nrf-2/HO-1 Signaling Axis: A Ray of Hope in Cardiovascular Diseases
Table 1
Functional effects of the Nrf2/HO-1 signaling axis in cardiovascular diseases.
| Cardiovascular disease | Effects | Reference |
| Viral myocarditis | Reduces inflammatory cytokine production and oxidative stress | [36] | Reduces CVB3-induced myocarditis by activating GSK-3β | [37] | Rheumatic heart disease (RHD) | Inhibits signal transducer | [39] | Cardiac tumors | Regulates antioxidant defense enzymes and counteracts oxidative stress | [40] | Reduces toxicity with sulforaphane | [41] | Myocardial infarction (MI) | Involved the renin-angiotensin-aldosterone system | [42] | Upgrades antioxidant genes | [43] | Myocardial ischemia reperfusion injury (MIRI) | Regulates the activation of thioredoxin-1 (Trx-1) through two antioxidant response elements | [45] | Regulates ROS levels | [46] | Atherosclerosis (AS) | Strengthens antioxidative potential and alleviates inflammation | [47] | Enhances the expression of HO-1 | [48] | Mediates atherosclerosis by saturated fatty acids | [49] | Arrhythmia | Produces antioxidant enzymes to reverse oxidative damage | [52] | Activates the NO pathway | [53] | Hypertensive heart disease | Reverses the mitochondrial apoptosis effect | [54] | Downregulates TGF-1/Smads in myocardial remodeling | [55] | Promotes lipolysis enzymatic activity | [56] |
|
|